Le Registre des lobbyistes
AbbVie Corporation
Objets | Détails | Catégories |
---|---|---|
Développement économique, Santé, Industrie
|
Canada’s Innovation and Skills Plan, led by Innovation, Science and Economic Development Canada, with respect to ensuring that the life sciences sector is a major focus of the government’s post-COVID recovery plan
|
Politique ou Programme
|
Budget, Santé, Industrie
|
Engagement with federal officials regarding Health Canada’s plans for the implementation of a national strategy for rare diseases, the Canada Drug Agency, and Bill C-64, An Act respecting National Pharmacare
|
Politique ou Programme
|
Développement économique, Santé, Industrie, Recherche et développement
|
Engagement with federal officials regarding Innovation, Science and Economic Development Canada’s plans for the creation of new biomanufacturing capacity for Canada
|
Politique ou Programme
|
Santé, Industrie
|
Engagement with officials regarding access and approval of mental health treatments and drugs.
|
Politique ou Programme
|
Budget, Santé
|
Federally-funded Public Drug Plans, with respect to reimbursement for drug products for federal plan beneficiaries.
|
Politique ou Programme
|
Budget, Santé, Industrie
|
Guidelines, policies and programs related to regulatory and reporting functions of the Patented Medicine Prices Review Board
|
Règlement, Politique ou Programme
|
Développement économique, Santé, Industrie, Propriété intellectuelle, Recherche et développement, Sciences et technologies
|
Innovation, Science and Economic Development Canada and Innovation Agenda, Science and Technology Strategy, or other Government policy or program initiatives to support research and development activities in Canada.
|
Politique ou Programme
|